Cargando…

Pharmaceutical innovation and access to financial markets

While prior research shows that pharmaceutical innovation generates measurable benefits for society, over the last 70 years, the innovative activities of pharmaceutical firms have dramatically declined. In this study, we develop and test the hypothesis that to innovate, pharmaceutical firms must hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blau, Benjamin M., Griffith, Todd G., Whitby, Ryan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767336/ https://www.ncbi.nlm.nih.gov/pubmed/36538526 http://dx.doi.org/10.1371/journal.pone.0278875

Ejemplares similares

Lobbying and lending by banks around the financial crisis by
por: Blau, ByBenjamin M., et al.
Publicado: (2022)

On the Ethics of “Non-Corporate” Insider Trading
por: Blau, Benjamin M., et al.
Publicado: (2021)

Fixing the Housing Market: Financial Innovations for the Future
por: Yago, Glenn
Publicado: (2012)

Pharmaceutical market access in emerging markets: concepts, components, and future
por: Kumar, Anuj, et al.
Publicado: (2014)

Drug repurposing in pharmaceutical industry and its impact on market access: market access implications
por: Murteira, Susana, et al.
Publicado: (2014)

Do retail traders destabilize financial markets? An investigation surrounding the COVID-19 pandemic()
por: Baig, Ahmed S., et al.
Publicado: (2022)

Innovative Financial Instruments and Investors’ Interest in Indian Securities Markets
por: Panda, Pradiptarathi
Publicado: (2023)

Range-based volatility, expected stock returns, and the low volatility anomaly
por: Blau, Benjamin M., et al.
Publicado: (2017)

Pharmaceutical Market Access: current state of affairs and key challenges – results of the Market Access Launch Excellence Inventory (MALEI)
por: Koch, Marcus A.
Publicado: (2015)

Association of exogenous factors with the access to innovative pharmaceutical products in Hungary
por: Merész, Gergő, et al.
Publicado: (2023)

Differential diffusion of pharmaceutical innovations in a mixed market middle - income economy
por: Md Hamzah, Nurhafiza, et al.
Publicado: (2021)

Reprint of: Do retail traders destabilize financial markets? An investigation surrounding the COVID-19 pandemic()()
por: Baig, Ahmed S., et al.
Publicado: (2023)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017)

Does Portuguese pharmaceutical market follow an innovative trend? The INFOMED database analysis
por: Avelar, FG, et al.
Publicado: (2022)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

Introduction to the special issue on analytical and decision-making technique innovation in financial market
por: Xu, Liang, et al.
Publicado: (2020)

New drug regulations in France: what are the impacts on market access? Part 2 – impacts on market access and impacts for the pharmaceutical industry
por: Rémuzat, Cécile, et al.
Publicado: (2013)

Organizational performance, Marketing strategy, and Financial strategic alignment: an empirical study on Iranian pharmaceutical firms
por: Mohammadzadeh, Mehdi, et al.
Publicado: (2013)

Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
por: Murteira, Susana, et al.
Publicado: (2014)

C# for financial markets
por: Duffy, Daniel J, et al.
Publicado: (2013)

Mathematics of financial markets
por: Elliott, Robert J, et al.
Publicado: (2005)

Mathematics of financial markets
por: Elliott, Robert J, et al.
Publicado: (1999)

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
por: Murteira, Susana, et al.
Publicado: (2013)

Public Policy and Pharmaceutical Innovation
por: Grabowski, Henry G.
Publicado: (1982)

Real-Time Diffusion of Information on Twitter and the Financial Markets
por: Tafti, Ali, et al.
Publicado: (2016)

Financial Symmetry and Moods in the Market
por: Savona, Roberto, et al.
Publicado: (2015)

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries
por: Panteli, Dimitra, et al.
Publicado: (2015)

PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities
por: Thomas, M., et al.
Publicado: (2020)

Financial institutions and markets/
por: Polakoff, Murray Emanuel, 1922-
Publicado: (1970)

Financial markets and the economy
por: Henning, Charles N.
Publicado: (1975)

The econometrics of financial markets
por: Campbell, John Y.
Publicado: (1997)

Financial Services Marketing
por: Ennew, Christine
Publicado: (2013)

Financial Markets for Commodities
por: Priolon, Joel
Publicado: (2019)

An Introduction to Financial Markets
por: Brandimarte, Paolo
Publicado: (2017)

Financial market complexity
por: Johnson, Neil F, et al.
Publicado: (2003)

COVID-19 pandemic and the crude oil market risk: hedging options with non-energy financial innovations
por: Salisu, Afees A., et al.
Publicado: (2021)

The Impact of Financial and Macroeconomic Shocks on the Entropy of Financial Markets
por: Anagnoste, Sorin, et al.
Publicado: (2019)

An introduction to trading in the financial markets: market basics
por: Williams, R Tee
Publicado: (2011)

Statistics of financial markets : an introduction /
por: Franke, Jürgen, 1952-
Publicado: (2004)

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_agb334u0ikgbfdf4q00gge2ohv